Packages

Quality control of Tc-99m MAA, particle size and count, suspension stability, lung perfusion studies, lung-shunt estimation, pre-therapy dosimetry and concordance with Y-90 distribution.

Quality control of HIDA, mebrofenin and disofenin, hepatic extraction and gallbladder ejection calculations, and hepatobiliary transit review.

Tc-99m HMPAO leukocyte labelling, labelling efficiency, cell viability and recovery, free activity, process time and temperature, and pre-reinjection release.

Sodium pertechnetate Tc-99m quality control and thyroid, salivary-gland, Meckel diverticulum and ectopic gastric-mucosa imaging workflows.

Red-cell mass and blood-volume calculations, Cr-51 labelling efficiency, elution correction, recovery-curve analysis and sample-timing control.

Gastric-emptying and GI-transit review, labelled-RBC gastrointestinal bleeding scintigraphy and Tc-99m colloid liver/spleen studies.

Tc-99m DTPA aerosol and Technegas control, aerosol-deposition review, V/Q mismatch evaluation and V/Q acquisition completeness.

Tc-99m nanocolloid and tilmanocept control, injection review, acquisition QC, node-detection threshold and shine-through assessment.

In-111 and Tc-99m platelet labelling, cell recovery, autologous-cell release and cell-viability control.

Ga-67 citrate, Tc-99m sulesomab and Tc-99m besilesomab control, plus antigranulocyte imaging acquisition review.